Muscle wasting in cancer and ageing: Cachexia versus sarcopenia

Sarcopenia - Age-Related Muscle Wasting and Weakness: Mechanisms and Treatments

Volumn , Issue , 2011, Pages 9-35

  Argilés, Josep M ^a   Busquets, Sílvia ^a   Orpi, Marcel ^a   Serpe, Roberto ^a   López Soriano, Francisco J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Ageing; Cancer cachexia; Cytokines; Mediators; Metabolic changes; Muscle wasting; Sarcopenia

Indexed keywords

EID: 84878558058     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-9713-2_2     Document Type: Chapter

References (145)

1. Abbasi, A. A. & Rudman, D. (1994). Undernutrition in the nursing home: prevalence, consequences, causes and prevention. Nutrition Reviews, 52, 113-122.
2. Acharyya, S., Ladner, K. J., Nelsen, L. L., Damrauer, J., Reiser, P. J., Swoap, S., Guttridge, D. C. (2004). Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. The Journal of Clinical Investigation, 114, 370-378.
3. Acharyya, S., Butchbach, M. E., Sahenk, Z., Wang, H., Saji, M., Carathers, M., Ringel, M. D., Skipworth, R. J., Fearon, K. C., Hollingsworth, M. A., Muscarella, P., Burghes, A. H., Rafael- Fortney, J. A., Guttridge, D. C. (2005). Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell, 8, 421-432.
4. Adams, M. & Victor, M. (1981). Asthenia. In Adams R, Victor M (Eds.), Principles of Neurology (pp. 341-345). New York: McGraw-Hill.
5. Adams, V., Gielen, S., Hambrecht, R., Schuler, G. (2001). Apoptosis in skeletal muscle. Frontiers in Bioscience, 6, D1-D11.
6. Agusti, A. G., Sauleda, J., Miralles, C., Gomez, C., Togores, B., Sala, E., Batle, S., Busquets, X. (2002). Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 166, 485-489.
7. Agustsson, T., Ryden, M., Hoffstedt, J., Van Harmelen, V., Dicker, A., Laurencikiene, J., Isaksson, B., Permert, J., Arner, P. (2007). Mechanism of increased lipolysis in cancer cachexia. Cancer Research, 67, 5531-5537.
8. Almendro, V., Carbo, N., Busquets, S., Figueras, M., Tessitore, L., Lopez-Soriano, F. J., Argiles, J. M. (2003). Sepsis induces DNA fragmentation in rat skeletal muscle. European Cytokine Network, 14, 256-259.
9. Alvarez, B., Quinn, L. S., Busquets, S., Quiles, M. T., Lopez-Soriano, F. J., Argiles, J. M. (2002). Tumor necrosis factor-alpha exerts interleukin-6-dependent and -independent effects on cultured skeletal muscle cells. Biochimica et Biophysica Acta, 1542, 66-72.
10. Annunziato, L., Pannaccione, A., Cataldi, M., Secondo, A., Castaldo, P., DI Renzo, G., Taglialatela, M. (2002). Modulation of ion channels by reactive oxygen and nitrogen species: a pathophysiological role in brain aging? Neurobiology of Aging, 23, 819-834.
11. Argiles, J. M., Garcia-Martinez, C., Llovera, M., Lopez-Soriano, F. J. (1992). The role of cytokines in muscle wasting: its relation with cancer cachexia. Medicinal Research Reviews, 12, 637-652.
12. Argiles, J. M., Alvarez, B., Lopez-Soriano, F. J. (1997). The metabolic basis of cancer cachexia. Medicinal Research Reviews, 17, 477-498.
13. Argiles, J. M., Busquets, S., Moore-Carrasco, R., Figueras, M., Almendro, V., Lopez-Soriano, F. J. (2007). Targets in clinical oncology: The metabolic environment of the patient. Frontiers in Bioscience, 12, 3024-3051.
14. Argiles, J. M., Lopez-Soriano, F. J., Busquets, S. (2008). Apoptosis signalling is essential and precedes protein degradation in wasting skeletal muscle during catabolic conditions. The International Journal of Biochemistry & Cell Biology, 40, 1674-1678.
15. Aubertin-Leheudre, M., Lord, C., Labonte, M., Khalil, A., Dionne, I. J. (2008). Relationship between sarcopenia and fracture risks in obese postmenopausal women. Journal of Women and Aging, 20, 297-308.
16. Bajaj, G. & Sharma, R. K. (2006). TNF-alpha-mediated cardiomyocyte apoptosis involves caspase- 12 and calpain. Biochemical and Biophysical Research Communications, 345, 1558-1564.
17. Baracos, V. E. (2000). Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia. Nutrition, 16, 1015-1018.
18. Baracos, V. E., Devivo, C., Hoyle, D. H., Goldberg, A. L. (1995). Activation of the ATP-ubiquitinproteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. The American Journal of Physiology, 268, E996-E1006.
19. Bastow, M. D., Rawlings, J., Allison, S. P. (1983). Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Ed.), 287, 1589-1592.
20. Belizario, J. E., Katz, M., Chenker, E., Raw, I. (1991). Bioactivity of skeletal muscle proteolysisinducing factors in the plasma proteins from cancer patients with weight loss. British Journal of Cancer, 63, 705-710.
21. Belizario, J. E., Lorite, M. J., Tisdale, M. J. (2001). Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia. British Journal of Cancer, 84, 1135-1140.
22. Benn, S. C. & Woolf, C. J. (2004). Adult neuron survival strategies-slamming on the brakes. Nature Reviews Neuroscience, 5, 686-700.
23. Bonetto, A., Penna, F., Minero, V. G., Reffo, P., Bonelli, G., Baccino, F. M., Costelli, P. (2009). Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice. Current Cancer Drug Targets, 9(5), 608-616.
24. Bossola, M., Muscaritoli, M., Costelli, P., Bellantone, R., Pacelli, F., Busquets, S., Argiles, J., Lopez- Soriano, F. J., Civello, I. M., Baccino, F. M., Rossi Fanelli, F., Doglietto, G. B. (2001). Increased muscle ubiquitin mRNA levels in gastric cancer patients. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 280, R1518-R1523.
25. Braga, M., Sinha Hikim, A. P., Datta, S., Ferrini, M. G., Brown, D., Kovacheva, E. L., Gonzalez- Cadavid, N. F., Sinha-Hikim, I. (2008). Involvement of oxidative stress and caspase 2-mediated intrinsic pathway signaling in age-related increase in muscle cell apoptosis in mice. Apoptosis, 13, 822-832.
26. Braun, J. V., Wykle, M. H., Cowling, W. R. 3rd (1988). Failure to thrive in older persons: a concept derived. The Gerontologist, 28, 809-812.
27. Brenner, D. A., O'HARA, M., Angel, P., Chojkier, M., Karin, M. (1989). Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature, 337, 661-663.
28. Busquets, S., Sanchis, D., Alvarez, B., Ricquier, D., Lopez-Soriano, F. J., Argiles, J. M. (1998). In the rat, tumor necrosis factor alpha administration results in an increase in both UCP2 and UCP3 mRNAs in skeletal muscle: a possible mechanism for cytokine-induced thermogenesis? FEBS Letters, 440, 348-350.
29. Busquets, S., Aranda, X., Ribas-Carbo, M., Azcon-Bieto, J., Lopez-Soriano, F. J., Argiles, J. M. (2003). Tumour necrosis factor-alpha uncouples respiration in isolated rat mitochondria. Cytokine, 22, 1-4.
30. Busquets, S., Figueras, M. T., Fuster, G., Almendro, V., Moore-Carrasco, R., Ametller, E., Argiles, J. M., Lopez-Soriano, F. J. (2004). Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Research, 64, 6725-6731.
31. Busquets, S., Deans, C., Figueras, M., Moore-Carrasco, R., Lopez-Soriano, F. J., Fearon, K. C., Argiles, J. M. (2007). Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients. Clinical Nutrition, 26, 614-618.
32. Cai, D., Frantz, J. D., Tawa, N. E., Melendez, P. A., Oh, B. C., Lidov, H. G., Hasselgren, P. O., Frontera, W. R., Lee, J., Glass, D. J., Shoelson, S. E. (2004). IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell, 119, 285-298.
33. Cannon, J. G. (1995) Cytokines in aging and muscle homeostasis. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 50 Spec No, 120-3.
34. Carbo, N., Busquets, S., van Royen, M., Alvarez, B., Lopez-Soriano, F. J., Argiles, J. M. (2002). TNF-alpha is involved in activating DNA fragmentation in skeletal muscle. British Journal of Cancer, 86, 1012-1016.
35. Carlin, C. R., Phillips, P. D., Knowles, B. B., Cristofalo, V. J. (1983). Diminished in vitro tyrosine kinase activity of the EGF receptor of senescent human fibroblasts. Nature, 306, 617-620.
36. Carter, W. J. & Lynch, M. E. (1994). Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats. Metabolism, 43, 1119-1125.
37. Coletti, D., Yang, E., Marazzi, G., Sassoon, D. (2002). TNF alpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways. The EMBO Journal, 21, 631-642.
38. Costelli, P., Garcia-Martinez, C., Llovera, M., Carbo, N., Lopez-Soriano, F. J., Agell, N., Tessitore, L., Baccino, F. M., Argiles, J. M. (1995). Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway. The Journal of Clinical Investigation, 95, 2367-2372.
39. Costelli, P., Muscaritoli, M., Bossola, M., Moore-Carrasco, R., Crepaldi, S., Grieco, G., Autelli, R., Bonelli, G., Pacelli, F., Lopez-Soriano, F. J., Argiles, J. M., Doglietto, G. B., Baccino, F. M., Rossi Fanelli, F. (2005a). Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation. International Journal of Oncology, 26, 1663-1668.
40. Costelli, P., Reffo, P., Penna, F., Autelli, R., Bonelli, G., Baccino, F. M. (2005b). Ca(2+)-dependent proteolysis in muscle wasting. The International Journal of Biochemistry and Cell Biology, 37, 2134-2146.
41. Costelli, P., Muscaritoli, M., Bossola, M., Penna, F., Reffo, P., Bonetto, A., Busquets, S., Bonelli, G., Lopez-Soriano, F. J., Doglietto, G. B., Argiles, J. M., Baccino, F. M., Rossi Fanelli, F. (2006). IGF-1 is downregulated in experimental cancer cachexia. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 291, R674-R683.
42. Chandra, R. K. (1983). Nutrition, immunity, and infection: present knowledge and future directions. Lancet, 1, 688-691.
43. Choi, S. E., Min, S. H., Shin, H. C., Kim, H. E., Jung, M. W., Kang, Y. (2006). Involvement of calcium-mediated apoptotic signals in H2O2-induced MIN6N8a cell death. European Journal of Pharmacology, 547, 1-9.
44. Dardevet, D., Sornet, C., Taillandier, D., Savary, I., Attaix, D., Grizard, J. (1995). Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging. The Journal of Clinical Investigation, 96, 2113-2119.
45. Dardevet, D., Sornet, C., Vary, T., Grizard, J. (1996). Phosphatidylinositol 3-kinase and p70 s6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin- like growth factor I. Endocrinology, 137, 4087-4094.
46. Dardevet, D., Sornet, C., Savary, I., Debras, E., Patureau-Mirand, P., Grizard, J. (1998). Glucocorticoid effects on insulin- And IGF-I-regulated muscle protein metabolism during aging. The Journal of Endocrinology, 156, 83-89.
47. Delbono, O. (2000). Regulation of excitation contraction coupling by insulin-like growth factor-1 in aging skeletal muscle. The Journal of Nutrition, Health & Aging, 4, 162-164.
48. Delbono, O. (2002). Molecular mechanisms and therapeutics of the deficit in specific force in ageing skeletal muscle. Biogerontology, 3, 265-270.
49. Dessi, S., Batetta, B., Pulisci, D., Accogli, P., Pani, P., Broccia, G. (1991). Total and HDL cholesterol in human hematologic neoplasms. International Journal of Hematology, 54, 483-486.
50. Dessi, S., Batetta, B., Anchisi, C., Pani, P., Costelli, P., Tessitore, L., Baccino, F. M. (1992). Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). British Journal of Cancer, 66, 787-793.
51. Dessi, S., Batetta, B., Spano, O., Bagby, G. J., Tessitore, L., Costelli, P., Baccino, F. M., Pani, P., Argiles, J. M. (1995). Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130). British Journal of Cancer, 72, 1138-1143.
52. Dewys, W. (1985). Management of cancer cachexia. Seminars in Oncology, 12, 452-460.
53. DI Giulio, C., Petruccelli, G., Bianchi, G., Cacchio, M., Verratti, V. (2009). Does hypoxia cause sarcopenia? Prevention of hypoxia could reduce sarcopenia. Journal of Biological Regulators and Homeostatic Agents, 23, 55-58.
54. Dirks Naylor, A. J. & Leeuwenburgh, C. (2008). Sarcopenia: The role of apoptosis and modulation by caloric restriction. Exercise and Sport Sciences Reviews, 36, 19-24.
55. Dirksen, R. T. (2002). Reactive oxygen/nitrogen species and the aged brain: radical impact of ion channel function. Neurobiology of Aging, 23, 837-839. discussion 841-2.
56. Du, J., Wang, X., Miereles, C., Bailey, J. L., Debigare, R., Zheng, B., Price, S. R., Mitch, W. E. (2004). Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. The Journal of Clinical Investigation, 113, 115-123.
57. Eisenberg, S. (1984). High density lipoprotein metabolism. Journal of Lipid Research, 25, 1017-1058.
58. Eley, H. L. & Tisdale, M. J. (2007). Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation. The Journal of Biological Chemistry, 282, 7087-7097.
59. Evans, R. D. & Williamson, D. H. (1988). Tissue-specific effects of rapid tumour growth on lipid metabolism in the rat during lactation and on litter removal. The Biochemical Journal, 252, 65-72.
60. Falconer, J. S., Fearon, K. C., Plester, C. E., Ross, J. A., Carter, D. C. (1994). Cytokines, the acutephase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Annals of Surgery, 219, 325-331.
61. Fearon, K. C., Falconer, J. S., Slater, C., Mcmillan, D. C., Ross, J. A., Preston, T. (1998). Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response. Annals of Surgery, 227, 249-254.
62. Fernandez-Celemin, L., Pasko, N., Blomart, V., Thissen, J. P. (2002). Inhibition of muscle insulinlike growth factor I expression by tumor necrosis factor-alpha. American Journal of Physiology. Endocrinology and Metabolism, 283, E1279-E1290.
63. Fernando, P., Kelly, J. F., Balazsi, K., Slack, R. S., Megeney, L. A. (2002). Caspase 3 activity is required for skeletal muscle differentiation. Proceedings of the National Academy of Sciences of the United States of America, 99, 11025-11030.
64. Ferreira, R., Neuparth, M. J., Ascensao, A., Magalhaes, J., Vitorino, R., Duarte, J. A., Amado, F. (2006). Skeletal muscle atrophy increases cell proliferation in mice gastrocnemius during the first week of hindlimb suspension. European Journal of Applied Physiology, 97, 340-346.
65. Fischer-Lougheed, J., Liu, J. H., Espinos, E., Mordasini, D., Bader, C. R., Belin, D., Bernheim, L. (2001). Human myoblast fusion requires expression of functional inward rectifier Kir2.1 channels. The Journal of Cell Biology, 153, 677-686.
66. Foster, T. C. & Kumar, A. (2002). Calcium dysregulation in the aging brain. The Neuroscientist, 8, 297-301.
67. Fuster, G., Busquets, S., Ametller, E., Olivan, M., Almendro, V., DE Oliveira, C. C., Figueras, M., Lopez-Soriano, F. J., Argiles, J. M. (2007). Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2- Adrenergic agonists. Cancer Research, 67, 6512-6519.
68. Gamper, N., Fillon, S., Huber, S. M., Feng, Y., Kobayashi, T., Cohen, P., Lang, F. (2002). IGF-1 up-regulates K+ channels via PI3-kinase, PDK1 and SGK1. Pflugers Archiv, 443, 625-634.
69. Glass, D. J. (2005). A signaling role for dystrophin: inhibiting skeletal muscle atrophy pathways. Cancer Cell, 8, 351-352.
70. Goodwin, J. S., Goodwin, J. M., Garry, P. J. (1983). Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA, 249, 2917-2921.
71. Grande, M., Suarez, E., Vicente, R., Canto, C., Coma, M., Tamkun, M. M., Zorzano, A., Guma, A., Felipe, A. (2003). Voltage-dependent K+ channel beta subunits in muscle: differential regulation during postnatal development and myogenesis. Journal of Cellular Physiology, 195, 187-193.
72. Grounds, M. D. (2002). Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling. Biogerontology, 3, 19-24.
73. Guttridge, D. C., Mayo, M. W., Madrid, L. V., Wang, C. Y., Baldwin, A. S. Jr. (2000). NF-kappaBinduced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science, 289, 2363-2366.
74. Hajnoczky, G., Csordas, G., Das, S., Garcia-Perez, C., Saotome, M., Sinha Roy, S., Yi, M. (2006). Mitochondrial calcium signalling and cell death: approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis. Cell Calcium, 40, 553-560.
75. Harley, C. B., Goldstein, S., Posner, B. I., Guyda, H. (1981). Decreased sensitivity of old and progeric human fibroblasts to a preparation of factors with insulinlike activity. The Journal of Clinical Investigation, 68, 988-994.
76. Harvey, K. B., Bothe, A. Jr., Blackburn, G. L. (1979). Nutritional assessment and patient outcome during oncological therapy. Cancer, 43, 2065-2069.
77. Hiona, A. & Leeuwenburgh, C. (2008). The role of mitochondrial DNA mutations in aging and sarcopenia: implications for the mitochondrial vicious cycle theory of aging. Experimental Gerontology, 43, 24-33.
78. Kirwan, J. P. & Del Aguila, L. F. (2003). Insulin signalling, exercise and cellular integrity. Biochemical Society Transactions, 31, 1281-1285.
79. Lambert, C. P., Sullivan, D. H., Freeling, S. A., Lindquist, D. M., Evans, W. J. (2002). Effects of testosterone replacement and/or resistance exercise on the composition of megestrol acetate J.M. Argilés et al. stimulated weight gain in elderly men: a randomized controlled trial. The Journal of Clinical Endocrinology and Metabolism, 87, 2100-2106.
80. Lanza-Jacoby, S., Lansey, S. C., Miller, E. E., Cleary, M. P. (1984). Sequential changes in the activities of lipoprotein lipase and lipogenic enzymes during tumor growth in rats. Cancer Research, 44, 5062-5067.
81. Latres, E., Amini, A. R., Amini, A. A., Griffiths, J., Martin, F. J., Wei, Y., Lin, H. C., Yancopoulos, G. D., Glass, D. J. (2005). Insulin- like growth factor-1 (IGF-1) inversely regulates atrophyinduced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. The Journal of Biological Chemistry, 280, 2737-2744.
82. Lee, C. E., Mcardle, A., Griffiths, R. D. (2007). The role of hormones, cytokines and heat shock proteins during age-related muscle loss. Clinical Nutrition, 26, 524-534.
83. Lee, S. W., Dai, G., Hu, Z., Wang, X., Du, J., Mitch, W. E. (2004). Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. Journal of the American Society of Nephrology, 15, 1537-1545.
84. Li, Y. P., Schwartz, R. J., Waddell, I. D., Holloway, B. R., Reid, M. B. (1998). Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. The FASEB Journal, 12, 871-880.
85. Lopez-Soriano, J., Argiles, J. M., Lopez-Soriano, F. J. (1996). Lipid metabolism in rats bearing the Yoshida AH-130 ascites hepatoma. Molecular and Cellular Biochemistry, 165, 17-23.
86. Lorite, M. J., Thompson, M. G., Drake, J. L., Carling, G., Tisdale, M. J. (1998). Mechanism of muscle protein degradation induced by a cancer cachectic factor. British Journal of Cancer, 78, 850-856.
87. Llovera, M., Garcia-Martinez, C., Agell, N., Marzabal, M., Lopez-Soriano, F. J., Argiles, J. M. (1994). Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Letters, 338, 311-318.
88. Llovera, M., Garcia-Martinez, C., Agell, N., Lopez-Soriano, F. J., Argiles, J. M. (1995). Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP dependent ubiquitin-mediated proteolysis. International Journal of Cancer, 61, 138-141.
89. Mahony, S. M., Beck, S. A., Tisdale, M. J. (1988). Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour. British Journal of Cancer, 57, 385-389.
90. Marton, K. I., Sox, H. C. Jr., Krupp, J. R. (1981). Involuntary weight loss: diagnostic and prognostic significance. Annals of Internal Medicine, 95, 568-574.
91. McFarlane, C., Plummer, E., Thomas, M., Hennebry, A., Ashby, M., Ling, N., Smith, H., Sharma, M., Kambadur, R. (2006). Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. Journal of Cellular Physiology, 209, 501-514.
92. McMurtry, C. T. & Rosenthal, A. (1995). Predictors of 2-year mortality among older male veterans on a geriatric rehabilitation unit. Journal of the American Geriatrics Society, 43, 1123-1126.
93. Moore-Carrasco, R., Garcia-Martinez, C., Busquets, S., Ametller, E., Barreiro, E., Lopez-Soriano, F. J., Argiles, J. M. (2006). The AP-1/CJUN signaling cascade is involved in muscle differentiation: implications in muscle wasting during cancer cachexia. FEBS Letters, 580, 691-696.
94. Morley, J. E. (2001). Anorexia, sarcopenia, and aging. Nutrition, 17, 660-663.
95. Morley, J. E. & Kraenzle, D. (1994). Causes of weight loss in a community nursing home. Journal of the American Geriatrics Society, 42, 583-585.
96. Morley, J. E. & Silver, A. J. (1988). Anorexia in the elderly. Neurobiology of Aging, 9, 9-16.
97. Moses, A. G., Maingay, J., Sangster, K., Fearon, K. C., Ross, J. A. (2009). Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival. Oncology Reports, 21, 1091-1095.
98. Moshage, H. (1997). Cytokines and the hepatic acute phase response. The Journal of Pathology, 181, 257-266.
99. Mosoni, L., Valluy, M. C., Serrurier, B., Prugnaud, J., Obled, C., Guezennec, C. Y., Mirand, P. P. (1995). Altered response of protein synthesis to nutritional state and endurance training in old rats. The American Journal of Physiology, 268, E328-E335.
100. Mulligan, H. D. & Tisdale, M. J. (1991). Lipogenesis in tumour and host tissues in mice bearing colonic adenocarcinomas. British Journal of Cancer, 63, 719-722.
101. Muscaritoli, M., Cangiano, C., Cascino, A., Ceci, F., Giacomelli, L., Cardelli-Cangiano, P., Mulieri, M., Rossi-Fanelli, F. (1990). Plasma clearance of exogenous lipids in patients with malignant disease. Nutrition, 6, 147-151.
102. Nixon, D. W., Heymsfield, S. B., Cohen, A. E., Kutner, M. H., Ansley, J., Lawson, D. H., Rudman, D. (1980). Protein-calorie undernutrition in hospitalized cancer patients. The American Journal of Medicine, 68, 683-690.
103. Noguchi, Y., Vydelingum, N. A., Younes, R. N., Fried, S. K., Brennan, M. F. (1991). Tumor-induced alterations in tissue lipoprotein lipase activity and mRNA levels. Cancer Research, 51, 863-869.
104. Pajak, B., Orzechowska, S., Pijet, B., Pijet, M., Pogorzelska, A., Gajkowska, B., Orzechowski, A. (2008). Crossroads of cytokine signaling-the chase to stop muscle cachexia. Journal of Physiology and Pharmacology, 59(Suppl 9), 251-264.
105. Patel, K. & Amthor, H. (2005). The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle. Neuromuscular Disorders, 15, 117-126.
106. Penner, C. G., Gang, G., Wray, C., Fischer, J. E., Hasselgren, P. O. (2001). The transcription factors NF-kappab and AP-1 are differentially regulated in skeletal muscle during sepsis. Biochemical and Biophysical Research Communications, 281, 1331-1336.
107. Penner, G., Gang, G., Sun, X., Wray, C., Hasselgren, P. O. (2002). C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 282, R439-R444.
108. Pinchcofsky-Devin, G. D. & Kaminski, M. V. Jr. (1986). Correlation of pressure sores and nutritional status. Journal of the American Geriatrics Society, 34, 435-440.
109. Plisko, A. & Gilchrest, B. A. (1983). Growth factor responsiveness of cultured human fibroblasts declines with age. Journal of Gerontology, 38, 513-518.
110. Puigserver, P., Rhee, J., Lin, J., Wu, Z., Yoon, J. C., Zhang, C. Y., Krauss, S., Mootha, V. K., Lowell, B. B., Spiegelman, B. M. (2001). Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Molecular Cell, 8, 971-982.
111. Rabinovitz, M., Pitlik, S. D., Leifer, M., Garty, M., Rosenfeld, J. B. (1986). Unintentional weight loss. A retrospective analysis of 154 cases. Archives of Internal Medicine, 146, 186-187.
112. Renganathan, M., Messi, M. L., Delbono, O. (1998). Overexpression of IGF-1 exclusively in skeletal muscle prevents age-related decline in the number of dihydropyridine receptors. The Journal of Biological Chemistry, 273, 28845-28851.
113. Rossi Fanelli, F., Cangiano, C., Muscaritoli, M., Conversano, L., Torelli, G. F., Cascino, A. (1995). Tumor-induced changes in host metabolism: a possible marker of neoplastic disease. Nutrition, 11, 595-600.
114. Russell, S. T. & Tisdale, M. J. (2005). The role of glucocorticoids in the induction of zinc-alpha2- glycoprotein expression in adipose tissue in cancer cachexia. British Journal of Cancer, 92, 876-881.
115. Russell, S. T., Zimmerman, T. P., Domin, B. A., Tisdale, M. J. (2004). Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein. Biochimica et Biophysica Acta, 1636, 59-68.
116. Ryden, M., Dicker, A., Van Harmelen, V., Hauner, H., Brunnberg, M., Perbeck, L., Lonnqvist, F., Arner, P. (2002). Mapping of early signaling events in tumor necrosis factor-alpha -mediated lipolysis in human fat cells. The Journal of Biological Chemistry, 277, 1085-1091.
117. Ryden, M., Arvidsson, E., Blomqvist, L., Perbeck, L., Dicker, A., Arner, P. (2004). Targets for TNF-alpha-induced lipolysis in human adipocytes. Biochemical and Biophysical Research Communications, 318, 168-175.
118. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., Goldberg, A. L. (2004). Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell, 117, 399-412.
119. Savary, I., Debras, E., Dardevet, D., Sornet, C., Capitan, P., Prugnaud, J., Mirand, P. P., Grizard, J. (1998). Effect of glucocorticoid excess on skeletal muscle and heart protein synthesis in adult and old rats. The British Journal of Nutrition, 79, 297-304.
120. Sciorati, C., Touvier, T., Buono, R., Pessina, P., Francois, S., Perrotta, C., Meneveri, R., Clementi, E., Brunelli, S. (2009). Necdin is expressed in cachectic skeletal muscle to protect fibers from tumor-induced wasting. Journal of Cell Science, 122, 1119-1125.
121. Schneider, S. M., Al-Jaouni, R., Pivot, X., Braulio, V. B., Rampal, P., Hebuterne, X. (2002). Lack of adaptation to severe malnutrition in elderly patients. Clinical Nutrition, 21, 499-504.
122. Sharma, R. & Anker, S. D. (2002). Cytokines, apoptosis and cachexia: The potential for TNF antagonism. International Journal of Cardiology, 85, 161-171.
123. Sinaud, S., Balage, M., Bayle, G., Dardevet, D., Vary, T. C., Kimball, S. R., Jefferson, L. S., Grizard, J. (1999). Diazoxide-induced insulin deficiency greatly reduced muscle protein synthesis in rats: involvement of eIF4E. The American Journal of Physiology, 276, E50-E61.
124. Slentz, C. A. & Holloszy, J. O. (1993). Body composition of physically inactive and active 25-month-old female rats. Mechanisms of Ageing and Development, 69, 161-166.
125. Smith, K. L. & Tisdale, M. J. (1993). Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia. British Journal of Cancer, 67, 680-685.
126. Stephens, N. A., Skipworth, R. J., Fearon, K. C. (2008). Cachexia, survival and the acute phase response. Current Opinion in Supportive and Palliative Care, 2, 267-274.
127. Sumi, T., Ishiko, O., Honda, K., Hirai, K., Yasui, T., Ogita, S. (1999). Muscle cell apoptosis is responsible for the body weight loss in tumor-bearing rabbits. Osaka City Medical Journal, 45, 25-35.
128. Temparis, S., Asensi, M., Taillandier, D., Aurousseau, E., Larbaud, D., Obled, A., Bechet, D., Ferrara, M., Estrela, J. M., Attaix, D. (1994). Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Research, 54, 5568-5573.
129. Thinakaran, G., Ojala, J., Bag, J. (1993). Expression of c-jun/AP-1 during myogenic differentiation in mouse C2C12 myoblasts. FEBS Letters, 319, 271-276.
130. Thompson, L. V. (2009). Age-related muscle dysfunction. Experimental Gerontology, 44, 106-111.
131. Thompson, M. P., Koons, J. E., Tan, E. T., Grigor, M. R. (1981). Modified lipoprotein lipase activities, rates of lipogenesis, and lipolysis as factors leading to lipid depletion in C57BL mice bearing the preputial gland tumor, ESR-586. Cancer Research, 41, 3228-3232.
132. Tracey, K. J., Morgello, S., Koplin, B., Fahey, T. J. 3RD., Fox, J., Aledo, A., Manogue, K. R., Cerami, A. (1990). Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. The Journal of Clinical Investigation, 86, 2014-2024.
133. Van Royen, M., Carbo, N., Busquets, S., Alvarez, B., Quinn, L. S., Lopez-Soriano, F. J., Argiles, J. M. (2000). DNA fragmentation occurs in skeletal muscle during tumor growth: A link with cancer cachexia? Biochemical and Biophysical Research Communications, 270, 533-537.
134. Vary, T., Dardevet, D., Grizard, J., Voisin, L., Buffiere, C., Denis, P., Breuille, D., Obled, C (1999). Pentoxifylline improves insulin action limiting skeletal muscle catabolism after infection. The Journal of Endocrinology, 163, 15-24.
135. Vary, T. C., Dardevet, D., Obled, C., Pouyet, C., Breuille, D., Grizard, J. (1997). Modulation of skeletal muscle lactate metabolism following bacteremia by insulin or insulin-like growth factor-I: effects of pentoxifylline. Shock, 7, 432-438.
136. Vary, T. C., Dardevet, D., Grizard, J., Voisin, L., Buffiere, C., Denis, P, Breuille, D., Obled, C. (1998). Differential regulation of skeletal muscle protein turnover by insulin and IGF-I after bacteremia. The American Journal of Physiology, 275, E584-E593.
137. Vescovo, G. & Dalla Libera, L. (2006). Skeletal muscle apoptosis in experimental heart failure: The only link between inflammation and skeletal muscle wastage? Current Opinion in Clinical Nutrition and Metabolic Care, 9, 416-422.
138. Wallace, J. I., Schwartz, R. S., Lacroix, A. Z., Uhlmann, R. F., Pearlman, R. A. (1995). Involuntary weight loss in older outpatients: incidence and clinical significance. Journal of the American Geriatrics Society, 43, 329-337.
139. Wang, X., Hu, Z., Hu, J., Du, J., Mitch, W. E. (2006). Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology, 147, 4160-4168.
140. Warren, S. (1932). The inmediate cause of death in cancer. The American Journal of the Medical Sciences, 184, 610-613.
141. Williams, A. B., Decourten-Myers, G. M., Fischer, J. E., Luo, G., Sun, X., Hasselgren, P. O. (1999). Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism. The FASEB Journal, 13, 1435-1443.
142. Workeneh, B. T., Rondon-Berrios, H., Zhang, L., Hu, Z., Ayehu, G., Ferrando, A., Kopple, J. D., Wang, H., Storer, T., Fournier, M., Lee, S. W., Du, J., Mitch, W. E. (2006). Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions. Journal of the American Society of Nephrology, 17, 3233-3239.
143. Wyke, S. M., Russell, S. T., Tisdale, M. J. (2004). Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation. British Journal of Cancer, 91, 1742-1750.
144. Wyke, S. M. & Tisdale, M. J. (2005). NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle. British Journal of Cancer, 92, 711-721.
145. Zhang, H. H., Halbleib, M., Ahmad, F., Manganiello, V. C., Greenberg, A. S. (2002). Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes, 51, 2929-2935.